A study of drug candidates derived from pleconaril for inhibiting coxsackievirus B3 (Cvb3) by ADMET, molecular docking, molecular dynamics and retrosynthesis

New J. Chem., 2022, Advance Article DOI: 10.1039/D2NJ01397E, PaperYouness Moukhliss, Yassine Koubi, Marwa Alaqarbeh, Nada Alsakhen, Samer Hamzeh, Hamid Maghat, Abdelouahid Sbai, Mohammed Bouachrine, Tahar Lakhlifi In the light of the serious diseases attributed to it, there is an urgent and inescapable need to hunt for antiviral medications for Coxsackievirus B3 (CVB3). To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry

Source: RSC - New J. Chem. latest articles - May 13, 2022 Category: Chemistry Authors: Youness Moukhliss Source Type: research